Bluelinx Holdings, Inc. (BXC) Narrows Q2 Loss to 6c/Share
Tweet
Share
E-mailGet Alerts BXC Hot Sheet
Price: $81.81 --0%
Revenue Growth %: +8.6%
Financial Fact:
Operating (loss) income: 22.62M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +8.6%
Financial Fact:
Operating (loss) income: 22.62M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bluelinx Holdings, Inc. (NYSE: BXC) reported Q2 EPS of ($0.06), versus ($0.31) reported last year. Revenue for the quarter came in at $517 million, versus $500.8 million reported last year.
For earnings history and earnings-related data on Bluelinx Holdings, Inc. (BXC) click here.
For earnings history and earnings-related data on Bluelinx Holdings, Inc. (BXC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch
- TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
